department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

lorigerlimab · pharmadog

pharmadog
drugs
lorigerlimab

drug · antibody

patient view →

lorigerlimab

Phase 2updated 2mo ago

by $MGNX MACROGENICS INC🔗 ChEMBL

Phase 2

community read0 votes

Antibody drug with a maximum clinical stage of Phase 2 (across all indications), with 3 investigational indications.

indications

indications

Colorectal CancerMelanoma

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

generic

lorigerlimab

indication

Colorectal Cancer

phase

phase_2

Data sources

ClinicalTrials.gov · OpenTargets

last refreshed 45m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Trials studying lorigerlimab

phase2Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)suspendedn=47
phase2A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancercompletedn=154
phase2A Study of Lorigerlimab in Participants With Advanced Solid Tumorsrecruitingn=60
phase2A Trial of Regorafenib Plus Lorigerlimab in Patients With Locally Recurrent or Regrowing pMMR/MSS Localized Rectal Cancerwithdrawn
phase2Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy [ReLOAD Trial]suspendedn=16
phase1A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumorscompletedn=31
phase1MGD019 DART® Protein in Unresectable/Metastatic Cancercompletedn=162